Z79.622
Long term (current) use of Janus kinase inhibitor
- Release
- FY 2027
- Effective
Hierarchy
Where Z79.622 sits in the official hierarchy. Each level is the code it is classified under.
- Z79 Long term (current) drug therapy
- Z79.6 Long term (current) use of immunomodulators and immunosuppressants
- Z79.62 Parent Long term (current) use of immunosuppressant
- Z79.622 This code Long term (current) use of Janus kinase inhibitor
Official Coding Notes
Reproduced verbatim from the FY 2027 ICD-10-CM files. Notes labelled as inherited are declared on a parent code and apply here too.
Includes
long term (current) drug use for prophylactic purposes
Inherited from Z79 — Long term (current) drug therapy
Inclusion Terms
Long term (current) use of tofacitinib
Excludes2
long term (current) use of steroids ( Z79.5- )
Inherited from Z79.6 — Long term (current) use of immunomodulators and immunosuppressants
Version History
How Z79.622 appears in each release imported from the official files, newest first.
-
FY 2027 Effective
CurrentLong term (current) use of Janus kinase inhibitor
-
FY 2026 Effective
UnchangedLong term (current) use of Janus kinase inhibitor
Related Codes
Other codes under Z79.62
- Z79.620 Long term (current) use of immunosuppressive biologic Billable
- Z79.621 Long term (current) use of calcineurin inhibitor Billable
- Z79.623 Long term (current) use of mammalian target of rapamycin (mTOR) inhibitor Billable
- Z79.624 Long term (current) use of inhibitors of nucleotide synthesis Billable
Data Source
Code information on this page is derived from the FY 2027 ICD-10-CM files published by CDC NCHS and CMS.
- Release
- FY 2027
- Effective
- Source file
- icd10cm-code-descriptions-2027.zip
Official ICD-10-CM source files (opens in a new tab)
MedCodeSearch is an independent reference service and is not affiliated with CMS, CDC, or the U.S. government.
Look up another code
Search ICD-10-CM, ICD-10-PCS and HCPCS Level II by code or description.